| Authors: |
Sæbø G; Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway gunnar.saebo@fhi.no., Lund I; Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway., Ollila H; Department of Healthcare and Social Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland., Ruokolainen O; Department of Healthcare and Social Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland., Laatikainen T; Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland., Carnicer-Pont D; Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.; Bellvitge Institute for Biomedical Research, Barcelona, Spain., Karekla M; University of Cyprus, Nicosia, Cyprus., Georgiou K; University of Cyprus, Nicosia, Cyprus., Koprivnikar H; Centre for Health Research and Development, National Institute of Public Health, Ljubljana, Slovenia., Vasic M; Institute of Public Health of Serbia 'Dr Milan Jovanovic Batut', Beograd, Serbia. |
